During the past decade, Segal Institute for Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Segal Institute for Clinical Research" #1 sponsor was "Sunovion" with 9 trials, followed by "Abbott" with 3 trials sponsored, "Curatek Pharmaceuticals, LLC" with 3 trials sponsored, "Becton, Dickinson and Company" with 2 trials sponsored and "Curemark" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Segal Institute for Clinical Research" #1 collaborator was "Chemo France" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Health Decisions" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Segal Institute for Clinical Research" are "Schizophrenia" (9 trials), "Autism" (3 trials), "Bipolar I Disorder" (3 trials), "Contraception" (3 trials) and "Vaginal Infection" (3 trials). Many other conditions were trialed in "Segal Institute for Clinical Research" in a lesser frequency.

Most popular intervention types in "Segal Institute for Clinical Research" are "Drug" (44 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Lurasidone" (3 trials), "CM-AT" (2 trials), "Colposcopy" (2 trials) and "Dasotraline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Segal Institute for Clinical Research" are 38 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Segal Institute for Clinical Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Segal Institute for Clinical Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Segal Institute for Clinical Research, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".